These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37691418)

  • 1. Subdivision of intermediate suspicion, the 2021 K-TIRADS, and category III, indeterminate cytology, the 2017 TBSRTC, 2nd edition, in thyroidology: let bygones be bygones?
    Sengul D; Sengul I
    Ultrasonography; 2023 Oct; 42(4):600-601. PubMed ID: 37691418
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Subdivision of intermediate suspicion, the 2021 K-TIRADS, and category III, indeterminate cytology, the 2017 TBSRTC, 2nd edition, in thyroidology: let bygones be bygones?
    Kim H; Hahn SY; Shin JH; Kim MK
    Ultrasonography; 2023 Oct; 42(4):602-603. PubMed ID: 37723648
    [No Abstract]   [Full Text] [Related]  

  • 3. Approach to Bethesda system category III thyroid nodules according to US-risk stratification.
    Kim J; Shin JH; Oh YL; Hahn SY; Park KW
    Endocr J; 2022 Jan; 69(1):67-74. PubMed ID: 34408101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indeterminate Thyroid Fine-Needle Aspirations in Pediatrics: Exploring Clinicopathologic Features and Utility of Molecular Profiling.
    Baran JA; Halada S; Bauer AJ; Ricarte-Filho JC; Isaza A; Surrey LF; McGrath C; Bhatti T; Jalaly J; Mostoufi-Moab S; Franco AT; Adzick NS; Kazahaya K; Cahill AM; Baloch Z
    Horm Res Paediatr; 2022; 95(5):430-441. PubMed ID: 35871517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology.
    Barbosa TLM; Junior COM; Graf H; Cavalvanti T; Trippia MA; da Silveira Ugino RT; de Oliveira GL; Granella VH; de Carvalho GA
    BMC Endocr Disord; 2019 Oct; 19(1):112. PubMed ID: 31664992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of The Bethesda System of Reporting Thyroid Cytopathology in Surgical Planning.
    Mahajan S; Manjula BV; Vaishnavi R; John N; Babu B
    Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):2623-2628. PubMed ID: 36452664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Bethesda System for Reporting Thyroid Cytology (TBSRTC): From look-backs to look-ahead.
    Baloch Z; LiVolsi VA
    Diagn Cytopathol; 2020 Oct; 48(10):862-866. PubMed ID: 31999070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comment on: "Evaluating treatment options in managing thyroid nodules with indeterminate cytology of TBSRTC in thyroidology: addendum aut non?".
    Sengul I; Sengul D
    Rev Assoc Med Bras (1992); 2022 Jul; 68(7):973-974. PubMed ID: 35946776
    [No Abstract]   [Full Text] [Related]  

  • 9. The combination of ACR-Thyroid Imaging Reporting and Data system and The Bethesda System for Reporting Thyroid Cytopathology in the evaluation of thyroid nodules-An institutional experience.
    Sakthisankari S; Vidhyalakshmi S; Shanthakumari S; Devanand B; Nagul U
    Cytopathology; 2021 Jul; 32(4):472-481. PubMed ID: 33606346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Korean vs. American Thyroid Imaging Reporting and Data System in Malignancy Risk Assessment of Indeterminate Thyroid Nodules.
    Kang S; Kwon SK; Choi HS; Kim MJ; Park YJ; Park DJ; Cho SW
    Endocrinol Metab (Seoul); 2021 Oct; 36(5):1111-1120. PubMed ID: 34674501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytology-Ultrasonography Risk-Stratification Scoring System Based on Fine-Needle Aspiration Cytology and the Korean-Thyroid Imaging Reporting and Data System.
    Hong MJ; Na DG; Baek JH; Sung JY; Kim JH
    Thyroid; 2017 Jul; 27(7):953-959. PubMed ID: 28463597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can the American Thyroid Association, K-Tirads, and Acr-Tirads Ultrasound Classification Systems Be Used to Predict Malignancy in Bethesda Category IV Nodules?
    Yang W; Fananapazir G; LaRoy J; Wilson M; Campbell MJ
    Endocr Pract; 2020 Sep; 26(9):945-952. PubMed ID: 33471698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Diovan scandal in Japan; don't let bygones be bygones.
    Murata N; Ozaki A; Murayama A; Sawano T; Tanimoto T
    J Hum Hypertens; 2022 May; 36(5):500-501. PubMed ID: 35351964
    [No Abstract]   [Full Text] [Related]  

  • 14. Contemporary/Ultrasound Guidance for Musculoskeletal Interventions: Let Bygones Be Bygones.
    Ricci V; Mezian K; Özçakar L
    Am J Phys Med Rehabil; 2021 Sep; 100(9):e134-e135. PubMed ID: 33443858
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnostic Value of Six Thyroid Imaging Reporting and Data Systems (TIRADS) in Cytologically Equivocal Thyroid Nodules.
    Słowińska-Klencka D; Wysocka-Konieczna K; Klencki M; Popowicz B
    J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32709122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TIRADS, SRE and SWE in INDETERMINATE thyroid nodule characterization: Which has better diagnostic performance?
    Celletti I; Fresilli D; De Vito C; Bononi M; Cardaccio S; Cozzolino A; Durante C; Grani G; Grimaldi G; Isidori AM; Catalano C; Cantisani V
    Radiol Med; 2021 Sep; 126(9):1189-1200. PubMed ID: 34129178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usability of EU-TIRADS in the Diagnostics of Hürthle Cell Thyroid Nodules with Equivocal Cytology.
    Słowińska-Klencka D; Wysocka-Konieczna K; Klencki M; Popowicz B
    J Clin Med; 2020 Oct; 9(11):. PubMed ID: 33114341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The thyroid risk score (TRS) for nodules with indeterminate cytology.
    Colombo C; Muzza M; Pogliaghi G; Palazzo S; Vannucchi G; Vicentini L; Persani L; Gazzano G; Fugazzola L
    Endocr Relat Cancer; 2021 Apr; 28(4):225-235. PubMed ID: 33640868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Bethesda System for Reporting Thyroid Cytopathology: proposed modifications and updates for the second edition from an international panel.
    Pusztaszeri M; Rossi ED; Auger M; Baloch Z; Bishop J; Bongiovanni M; Chandra A; Cochand-Priollet B; Fadda G; Hirokawa M; Hong S; Kakudo K; Krane JF; Nayar R; Parangi S; Schmitt F; Faquin WC
    J Am Soc Cytopathol; 2016; 5(5):245-251. PubMed ID: 31042501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasonographic characteristics of medullary thyroid carcinoma according to nodule size: application of the Korean Thyroid Imaging Reporting and Data System and American Thyroid Association guidelines.
    Hahn SY; Shin JH; Oh YL; Park KW
    Acta Radiol; 2021 Apr; 62(4):474-482. PubMed ID: 32493032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.